https://www.europesays.com/dk/175926/ Novo Nordisk Bets On Once-Weekly China Developed Obesity Pill In Deal Worth $2.6 Billion #DiabetesDrugPricing #DiabetesDrugs #DiabetesDrugsForWeightLoss #DiabetesDrugsGLP1RAsMayReduceStrokeRiskStudy #DiabetesDrugsInIndia #DiabetesPills #NovoNordisk #NovoNordiskObesityPill #NovoNordiskOnceWeeklyDiabetesPill #NovoNordiskOnceWeeklyObesityPill #ObesityPills #OnceWeeklyDiabetesPill #OnceWeeklyObesityPill
#diabetesdrugs — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #diabetesdrugs, aggregated by home.social.
-
https://www.europesays.com/dk/173204/ U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast #CentralBank #DanishEconomy #DanmarksNationalbank #DiabetesDrugs #GrowthEstimates #GrowthForecasts #HealthcareBenefits #NovoNordisk #PharmaceuticalIndustry #WeightLossDrugs
-
https://www.europesays.com/dk/173060/ NVO Stock On Track For Worst Week In Over 6 Months After Strategy Day — Direct US Listing Talks, Drug Approval Fail To Halt Slip #ActiveProcess #DiabetesDrugs #InvestorSentiment #MikeDoustdar #NovoNordisk #NVOStock #NYSE #ObesityAndDiabetes #Singapore
-
https://www.europesays.com/ie/701212/ Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations – finance.yahoo.com #CapitalMarkets #DiabetesDrugs #Éire #EliLilly #exclusivity #Health #IE #Ireland #Medication #NovoNordisk
-
https://www.europesays.com/dk/172047/ Novo Nordisk, Eli Lilly sued over weight loss drugs and vision loss #DiabetesDrugs #EliLilly #Journal #NAION #NovoNordisk #patients #WallStreetJournal
-
Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations – Yahoo Finance
Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations Yahoo FinanceNovo shares slide as drugmaker lays out post-Wegovy growth…
#NewsBeep #News #Medication #CapitalMarkets #diabetesdrugs #EliLilly #Exclusivity #Health #NovoNordisk #UK #UnitedKingdom
https://www.newsbeep.com/uk/778052/ -
https://www.europesays.com/dk/169032/ Novo Nordisk’s hemophilia drug clears a key hurdle in Europe #CommercialOpportunity #DiabetesDrugs #EuropeanCommission #EuropeanMarket #EuropeanMedicinesAgency #NovoNordisk #ObesityTreatments
-
Eli Lilly Just Scored Europe’s First Weight Loss Pill Approval — and the Growth Story Keeps Getting Bigger
This week, the U.K.’s healthcare regulatory body approved Eli Lilly’s (NYSE: LLY) weight loss drug orforglipron, sold as…
#Europe #EU #diabetesdrugs #EliLilly #injectabledrugs #NovoNordisk #NYSE #type2diabetes #weightlossdrug #WeightManagement
https://www.europesays.com/europe/116258/ -
https://www.europesays.com/dk/141299/ Lilly’s Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk #DanishCrowns #DiabetesDrugs #EliLilly #Mounjaro #NovoNordisk #QuarterlySales
-
https://www.europesays.com/dk/135781/ Novo Nordisk seeks orders to block Eli Lilly weight-loss drug ads | World News #DiabetesDrugs #DrugAdvertising #DrugMarketing #EliLilly #GLP1Drugs #HealthcareNews #MisleadingAds #Mounjaro #NovoNordisk #ObesityDrugs #ObesityTreatment #ozempic #PharmaceuticalIndustry #PreliminaryInjunction #USCourt #USLawsuit #Wegovy #WeightLossDrugs #WeightLossMarket #zepbound
-
https://www.europesays.com/dk/134934/ Novo Nordisk (CPSE:NOVO B) Sues Eli Lilly Over GLP 1 Drug Advertising #Advertising #CompetitiveEdge #DiabetesDrugs #DiabetesTreatments #EliLilly #MisleadingAdvertising #NovoNordisk #Obesity
-
https://www.europesays.com/dk/116361/ An Analyst Just Declared Eli Lilly the “Clear Winner” of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo’s Chief Scientist Disagrees. Who’s Right? #ADAConference #AmericanDiabetesAssociation #DiabetesDrugs #Lilly #MartinHolstLange #NovoNordisk #PositiveGrowth #TrungHuynh #WeightLoss
-
https://www.europesays.com/britain/67394/ AstraZeneca profits jump by 40% amid strong demand for cancer drugs #AstraZeneca #BillionDollars #CurrencyBasis #DiabetesDrugs
-
https://www.europesays.com/ie/531302/ Generic semaglutide market shows signs of excess inventory bulge | Industry News #DiabetesDrugs #DrReddy's #Éire #GenericSemaglutide #Glenmark #GLP1 #Health #IE #Ireland #MankindPharma #Medication #NovoNordisk #ObesityDrugs #Pharmarack #semaglutide
-
https://www.europesays.com/dk/104744/ Novo Nordisk faces off in court with South African weight-loss drug compounder #DiabetesDrugs #NovoNordisk #SouthAfrica #WeightLoss #WeightLossProducts
-
https://www.europesays.com/dk/104512/ Novo Nordisk faces off in court with South African weight-loss drug compounder #DiabetesDrugs #NovoNordisk #SouthAfrica #WeightLoss #WeightLossProducts
-
https://www.europesays.com/africa/277098/ Novo Nordisk faces off in court with South African weight-loss drug compounder #Africa #DiabetesDrugs #NovoNordisk #SouthAfrica #WeightLoss #WeightLossProducts
-
https://www.europesays.com/dk/101075/ Beyond GLP-1, Novo eyes next-gen obesity drugs: Vikrant Shrotriya | People #Amycretin #AntiObesityDrugsIndia #cagrisema #DiabetesDrugs #GLP1Therapies #HealthcareInnovation #InsulinIcodec #MetabolicTherapies #NovoNordisk #ObesityTreatmentIndia #OralObesityDrugs #PharmaceuticalCompetition #SemaglutidePatentExpiry #Wegovy®HD #WeightLossDrugs
-
https://www.europesays.com/ie/512344/ Could GLP-1 drugs become oncology’s next big opportunity? #AmericanSocietyOfClinicalOncology #BreastCancer #CancerPrevention #Citi #ColorectalCancer #DiabetesDrugs #Éire #GLP1ReceptorAgonist #Health #IE #Ireland #LiverCancer #LungCancer #OncologyStudies
-
Ozempic may be reshaping the brain, scientists say
Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant…
#NewsBeep #News #Medication #AllisonShapiro #diabetesdrugs #Health #researchers #scientists #UK #UnitedKingdom
https://www.newsbeep.com/uk/614053/ -
Ozempic may be reshaping the brain, scientists say
Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant…
#NewsBeep #News #Medication #AllisonShapiro #AU #Australia #diabetesdrugs #Health #Researchers #scientists
https://www.newsbeep.com/au/706058/ -
Ozempic may be reshaping the brain, scientists say
Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant…
#NewsBeep #News #Medication #AllisonShapiro #CA #Canada #diabetesdrugs #Health #researchers #scientists
https://www.newsbeep.com/ca/705573/ -
https://www.europesays.com/ie/511425/ Ozempic may be reshaping the brain, scientists say #AllisonShapiro #DiabetesDrugs #Éire #Health #IE #Ireland #Medication #Researchers #Scientists
-
https://www.europesays.com/uk/995983/ Ozempic may be reshaping the brain, scientists say #AllisonShapiro #DiabetesDrugs #Health #Medication #researchers #scientists #UK #UnitedKingdom
-
https://www.europesays.com/britain/49943/ AstraZeneca shares launch on New York Stock Exchange #AstraZeneca #CapitalMarket #DiabetesDrugs #GlobalGrowth #LondonStockExchange #LynnMartin #NewYorkStockExchange
-
https://www.europesays.com/dk/90502/ Novo Nordisk Turns to AI and Bengaluru to Speed Up Global Drug Launches – Outlook Business #AIDrugLaunches #AIInPharma #BangaloreGBS #BengaluruHub #ClinicalData #DiabetesDrugs #DrugLaunchSpeed #IndiaGenerics #NovoNordisk #ObesityPill #OzempicPrice #PharmaRestructuring #RegulatoryAI #SemaglutidePatent #WegovyPrice
-
https://www.europesays.com/dk/53034/ Novo Nordisk Tests Pricing Power With Wegovy Subscriptions And India Cuts #DiabetesDrugs #India #NovoNordisk #patients #PricingPower #subscription #Wegovy
-
https://www.europesays.com/dk/43583/ Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India #DiabetesDrugs #GenericDrugPricing #IndianPharmaceuticalMarket #NovoNordisk #NovoNordiskPatentExpiry #ObesityTreatmentInIndia #SemaglutideGenerics #WeightLossDrugs
-
Large Veterans Study Shows How GLP-1 Weight Loss Drugs Could Treat Addiction
Credit: MotivateBootCamp. Drugs originally designed to treat diabetes and obesity are reshaping medicine in unforeseen ways. Their impact…
#NewsBeep #News #Health #Addictionresearch #alcoholusedisorder #brainrewardsystem #CA #Canada #diabetesdrugs #dopamine #glp-1drugs #metabolichealth #Neuroscience #obesitytreatment #opioidaddiction #Semaglutide #substanceusedisorder #VAstudy
https://www.newsbeep.com/ca/527512/